1. Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease 
James Markowitz, Jeffrey Hyams, David Mack, Neal LeLeiko, Jonathan Evans, Subra Kugathasan, Marian Pfefferkorn, Adam Mezoff, Joel Rosh, Vasundhara Tolia, Anthony Otley, Anne Griffiths, M. Susan Moyer, Maria Oliva–Hemker, Robert Wyllie, Robert Rothbaum, Athos Bousvaros, J. Fernando Del Rosario, Sandra Hale, Trudy Lerer 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 9, Pages (September 2006)
DOI: /j.cgh
Copyright © 2006 American Gastroenterological Association Terms and Conditions

2. Figure 1
Percent of the population on continuous corticosteroid therapy over time.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

3. Figure 2
One-year response to corticosteroid (CS) treatment as a function of 3-month response. cs, corticosteroid. ▩, Surgery; □, CS dependent; ▨, prolonged response.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

4. Figure 3 Summary of acute and 1-year outcomes.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions